[1]
|
Luo, D., Zhan, S., Xia, W., Huang, L., et al. (2018) Proteomics Study of Serum Exosomes from Papillary Thyroid Can-cer Patients. Endocrine-Related Cancer, 25, 879-891. https://doi.org/10.1530/ERC-17-0547
|
[2]
|
Vaccarella, S., Franceschi, S., Bray, F., et al. (2016) Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. The New England Journal of Medicine, 375, 614-617. https://doi.org/10.1056/NEJMp1604412
|
[3]
|
Wiest, P.W., Hartshorne, M.F., Inskip, P.D., et al. (1998) Thyroid Palpation versus High-Resolution Thyroid Ultrasonography in the Detection of Nodules. Journal of Ultrasound in Medicine, 17, 487-496.
https://doi.org/10.7863/jum.1998.17.8.487
|
[4]
|
Limaiem, F., Rehman, A., Anastasopoulou, C. and Mazzoni, T. (2022) Papillary Thyroid Carcinoma. StatPearls Publishing, Treasure Island.
|
[5]
|
Yip, L., Kelly, L., Shuai, Y., et al. (2011) MicroRNA Signature Distinguishes the Degree of Aggressiveness of Papillary Thyroid Carcinoma. Annals of Surgical Oncology, 18, 2035-2041. https://doi.org/10.1245/s10434-011-1733-0
|
[6]
|
Kuo, E.J., Goffredo, P., Sosa, J.A. and Roman, S.A. (2013) Aggressive Variants of Papillary Thyroid Microcarcinoma Are Associated with Extrathy-roidal Spread and Lymph-Node Metastases: A Population-Level Analysis. Thyroid, 23, 1305-1311. https://doi.org/10.1089/thy.2012.0563
|
[7]
|
Haugen, B.R., Alexander, E.K., Bible, K.C., et al. (2016) 2015 Ameri-can Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Can-cer. Thyroid, 26, 1-133.
https://doi.org/10.1089/thy.2015.0020
|
[8]
|
Lin, P., Yao, Z., Sun, Y., Li, W., et al. (2019) Deciphering Novel Bi-omarkers of Lymph Node Metastasis of Thyroid Papillary Microcarcinoma Using Proteomic Analysis of Ultra-sound-Guided Fine-Needle Aspiration Biopsy Samples. Journal of Proteomics, 204, Article ID: 103414. https://doi.org/10.1016/j.jprot.2019.103414
|
[9]
|
Feng, J.W., Ye, J., Wu, W.X., et al. (2020) Management of cN0 Papillary Thyroid Microcarcinoma Patients According to Risk-Scoring Model for Central Lymph Node Metastasis and Predictors of Recurrence. Journal of Endocrinological Investigation, 43, 1807-1817. https://doi.org/10.1007/s40618-020-01326-1
|
[10]
|
Ito, Y., Tomoda, C., Uruno, T., et al. (2005) Ultrasonograph-ically and Anatomopathologically Detectable Node Metastases in the Lateral Compartment as Indicators of Worse Re-lapse-Free Survival in Patients with Papillary Thyroid Carcinoma. World Journal of Surgery, 29, 917-920. https://doi.org/10.1007/s00268-005-7789-x
|
[11]
|
Anastasilakis, A.D., Polyzos, S.A., Makras, P., et al. (2012) Pa-pillary Thyroid Microcarcinoma Presenting as Lymph Node Metastasis—A Diagnostic Challenge: Case Report and Sys-tematic Review of Literature. Hormones (Athens), 11, 419-427. https://doi.org/10.14310/horm.2002.1373
|
[12]
|
Tannu, N.S. and Hemby, S.E. (2006) Two-Dimensional Fluores-cence Difference Gel Electrophoresis for Comparative Proteomics Profiling. Nature Protocols, 1, 1732-1742. https://doi.org/10.1038/nprot.2006.256
|
[13]
|
Chen, H. and Horváth, C. (1995) High-Speed High-Performance Liq-uid Chromatography of Peptides and Proteins. Journal of Chromatography A, 705, 3-20. https://doi.org/10.1016/0021-9673(94)01254-C
|
[14]
|
Rozanova, S., Barkovits, K., Nikolov, M., et al. (2021) Quan-titative Mass Spectrometry-Based Proteomics: An Overview. Methods in Molecular Biology, 2228, 85-116. https://doi.org/10.1007/978-1-0716-1024-4_8
|
[15]
|
Urban, P.L. (2016) Quantitative Mass Spectrometry: An Over-view. Philosophical Transactions: Mathematical, Physical and Engineering Sciences, 374, Article ID: 20150382. https://doi.org/10.1098/rsta.2015.0382
|
[16]
|
Pappireddi, N., Martin, L. and Wühr, M. (2019) A Review on Quanti-tative Multiplexed Proteomics. Chembiochem, 20, 1210-1224. https://doi.org/10.1002/cbic.201800650
|
[17]
|
Layton, C.J., McMahon, P.L. and Greenleaf, W.J. (2019) Large-Scale, Quantitative Protein Assays on a High-Throughput DNA Sequencing Chip. Molecular Cell, 73, 1075-1082.e4.
https://doi.org/10.1016/j.molcel.2019.02.019
|
[18]
|
Bomeli, S.R., LeBeau, S.O. and Ferris, R.L. (2010) Evaluation of a Thyroid Nodule. Otolaryngologic Clinics of North America, 43, 229-238. https://doi.org/10.1016/j.otc.2010.01.002
|
[19]
|
So, A.K., Kaur, J., Kak, I., et al. (2012) Biotinidase Is a Novel Marker for Papillary Thyroid Cancer Aggressiveness. PLOS ONE, 7, e40956. https://doi.org/10.1371/journal.pone.0040956
|
[20]
|
Nipp, M., Elsner, M., Balluff, B., et al. (2012) S100-A10, Thi-oredoxin, and S100-A6 as Biomarkers of Papillary Thyroid Carcinoma with Lymph Node Metastasis Identified by MALDI Imaging. Journal of Molecular Medicine (Berlin), 90, 163-174. https://doi.org/10.1007/s00109-011-0815-6
|
[21]
|
Cao, Z., Zhang, Z., Tang, X., et al. (2022) Comprehensive Analy-sis of Tissue Proteomics in Patients with Papillary Thyroid Microcarcinoma Uncovers the Underlying Mechanism of Lymph Node Metastasis and Its Significant Sex Disparities. Frontiers in Oncology, 12, Article ID: 887977. https://doi.org/10.3389/fonc.2022.887977
|
[22]
|
Zhan, S., Wang, T., Li, J., et al. (2022) Asporin Interacts with HER2 to Promote Thyroid Cancer Metastasis via the MAPK/EMT Signaling Pathway. Frontiers in Oncology, 12, Article ID: 762180.
https://doi.org/10.3389/fonc.2022.762180
|
[23]
|
Dai, J., Yu, X., Han, Y., et al. (2020) TMT-Labeling Proteomics of Papillary Thyroid Carcinoma Reveal Invasive Biomarkers. Journal of Cancer, 11, 6122-6132. https://doi.org/10.7150/jca.47290
|